A short survival time after last psychiatric hospitalization in drivers with psychotic disorder killed in fatal motor vehicle accidents.


Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
02 2020
Historique:
received: 08 04 2019
revised: 20 10 2019
accepted: 26 11 2019
pubmed: 10 12 2019
medline: 22 6 2021
entrez: 10 12 2019
Statut: ppublish

Résumé

Research-based evidence on patients with psychotic disorders involved in fatal motor vehicle accidents (FMVA) remains limited. The current study analyzes the characteristics of FMVA drivers, who had been hospitalized due to psychotic disorders within a five-year-time-period prior to their death in traffic accidents. Data sources included three national registers: The Finnish Database of Road and Cross-Country Accidents, the Care Register for Health Care and the National Cause of Death Register. The register-linkage was made using personal identity codes, unique for each Finnish citizen. The initial study population consisted of 4930 drivers killed in FMVA in Finland between the years 1990-2011. A total of 94 (1.9%) Finnish drivers had a hospital-diagnosed psychotic disorder made during the five years preceding their FMVA. The psychotic disorders of the study subjects were categorized into: schizophrenia (n = 27, 28.7%), other specified psychoses (n = 39, 41.5%) and unspecified psychoses (n = 28, 29.8%). About one half of the FMVA drivers with schizophrenia or unspecified psychoses and 41% of those with other specified psychoses had been discharged from psychiatric care within three months prior to their death in traffic accidents. Based on our study findings and the lack of concise guidelines for assessing psychotic patients' fitness-to-drive, we recommend a minimum temporary driving restriction of three months for all patients after hospitalization for psychosis.

Sections du résumé

BACKGROUND
Research-based evidence on patients with psychotic disorders involved in fatal motor vehicle accidents (FMVA) remains limited. The current study analyzes the characteristics of FMVA drivers, who had been hospitalized due to psychotic disorders within a five-year-time-period prior to their death in traffic accidents.
MATERIAL AND METHODS
Data sources included three national registers: The Finnish Database of Road and Cross-Country Accidents, the Care Register for Health Care and the National Cause of Death Register. The register-linkage was made using personal identity codes, unique for each Finnish citizen. The initial study population consisted of 4930 drivers killed in FMVA in Finland between the years 1990-2011. A total of 94 (1.9%) Finnish drivers had a hospital-diagnosed psychotic disorder made during the five years preceding their FMVA. The psychotic disorders of the study subjects were categorized into: schizophrenia (n = 27, 28.7%), other specified psychoses (n = 39, 41.5%) and unspecified psychoses (n = 28, 29.8%).
RESULTS
About one half of the FMVA drivers with schizophrenia or unspecified psychoses and 41% of those with other specified psychoses had been discharged from psychiatric care within three months prior to their death in traffic accidents.
CONCLUSIONS
Based on our study findings and the lack of concise guidelines for assessing psychotic patients' fitness-to-drive, we recommend a minimum temporary driving restriction of three months for all patients after hospitalization for psychosis.

Identifiants

pubmed: 31813802
pii: S0920-9964(19)30560-2
doi: 10.1016/j.schres.2019.11.053
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

235-242

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None declared.

Auteurs

Tommi Keski-Filppula (T)

Department of Psychiatry, Research Unit of Clinical Neuroscience, University of Oulu, P.O. BOX 5000, FIN 90014 OYS, Finland. Electronic address: tommi.keski-filppula@student.oulu.fi.

Helinä Hakko (H)

Oulu University Hospital, Department of Psychiatry, P.O. BOX 26, FIN 90029 OYS, Finland. Electronic address: helina.hakko@oulu.fi.

Esa Räty (E)

The Finnish Crash Data Institute OTI, Itämerenkatu 11-13, FI-00180 Helsinki, Finland. Electronic address: esa.raty@oti.fi.

Kaisa Riala (K)

Oulu University Hospital, Department of Psychiatry, P.O. BOX 26, FIN 90029 OYS, Finland. Electronic address: kaisa.riala@oulu.fi.

Pirkko Riipinen (P)

Department of Psychiatry, Research Unit of Clinical Neuroscience, University of Oulu, P.O. BOX 5000, FIN 90014 OYS, Finland. Electronic address: pirkko.riipinen@oulu.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH